Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Growth 2025-2031

The global ICAD (Intracranial Atherosclerotic Disease) Pathology market size is predicted to grow from US$ 201 million in 2025 to US$ 340 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031.

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

LP Information, Inc. (LPI) ' newest research report, the “ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Forecast” looks at past sales and reviews total world ICAD (Intracranial Atherosclerotic Disease) Pathology sales in 2024, providing a comprehensive analysis by region and market sector of projected ICAD (Intracranial Atherosclerotic Disease) Pathology sales for 2025 through 2031. With ICAD (Intracranial Atherosclerotic Disease) Pathology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ICAD (Intracranial Atherosclerotic Disease) Pathology industry.

This Insight Report provides a comprehensive analysis of the global ICAD (Intracranial Atherosclerotic Disease) Pathology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ICAD (Intracranial Atherosclerotic Disease) Pathology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ICAD (Intracranial Atherosclerotic Disease) Pathology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ICAD (Intracranial Atherosclerotic Disease) Pathology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ICAD (Intracranial Atherosclerotic Disease) Pathology.

This report presents a comprehensive overview, market shares, and growth opportunities of ICAD (Intracranial Atherosclerotic Disease) Pathology market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Stent
PTA Balloon

Segmentation by Application:
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Stryker
Balt
TERUMO
MicroPort
Acandis

Key Questions Addressed in this Report

What is the 10-year outlook for the global ICAD (Intracranial Atherosclerotic Disease) Pathology market?

What factors are driving ICAD (Intracranial Atherosclerotic Disease) Pathology market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do ICAD (Intracranial Atherosclerotic Disease) Pathology market opportunities vary by end market size?

How does ICAD (Intracranial Atherosclerotic Disease) Pathology break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.